A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(94 sites)

United States

Mayo Clinic Hospital Scottsdale, Phoenix, Arizona

University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California

Sharp Memorial Hospital, Oceanside, California

University of Colorado Hospital, Aurora, Colorado

Yale University School of Medicine, New Haven, Connecticut